Pharma intelligence in minutes,
not meetings.
FDA approvals, trials, patents, pipelines — into clear decisions, fast.
Try:
·
·
·
·
·
8,600+ drugs · 150,000+ trials · 1,300+ patent landscapes · Updated weekly.
Start 30-day Pro trial — free →
No credit card required
Questions TheraRadar answers
Tap any question to jump straight to the data.
Recent FDA Approvals
Updated Jul 17, 2026
Upcoming FDA Decisions
Full calendarPivekimab sunirine (PVEK)
AbbVie Inc.
2026-07-30
2d away
mRNA-1010
Moderna, Inc.
2026-08-05
8d away
Oveporexton (TAK-861)
Takeda Pharmaceutical Co., Ltd.
2026-08-10
13d away
Latest brief The Disease That Wasn't Rare After All
All briefs → Pro tools
Pre-built analyses. The slow research is already done.
🧬
Competitive heatmaps
90+ interactive grids — indication landscapes (company × mechanism), company portfolios, and MOA platforms. Click any cell to drill into the trials.
⚖️
Compare two companies
Head-to-head comparison of any two company portfolios — pipeline, approvals, and revenue side by side.
🔬
Clinical Trials Explorer
Search and filter 150,000+ trials by drug, sponsor, phase, and condition.
📉
Patent Cliff with revenue arcs
Humira -73%, Revlimid -81%, Stelara -43% — actual SEC revenue declines, not Medicare proxies.
Data sources: FDA Drugs@FDA, ClinicalTrials.gov, Orange Book, SEC EDGAR.
Data updated: Jul 17, 2026